The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity

Oncogene

Volumn 32, Issue 10, 2013, Pages 1284-1295

  Paul, I ^a   Ahmed, S F ^a   Bhowmik, A ^a   Deb, S ^a   Ghosh, M K ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

c Myc; CHIP (STUB1); Hsp70; Hsp90; proteasome

Indexed keywords

BCR ABL PROTEIN; CARBOXYL TERMINUS OF HSC7 INTERACTING PROTEIN; CHAPERONE; MYC PROTEIN; PROTEIN KINASE B; TELOMERASE REVERSE TRANSCRIPTASE; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; TETRATRICOPEPTIDE REPEAT; TUMOR SUPPRESSOR GENE; TURNOVER TIME;

ANIMALS; CELL LINE, TUMOR; GENE KNOCKDOWN TECHNIQUES; GLIOMA; HCT116 CELLS; HEK293 CELLS; HSP70 HEAT-SHOCK PROTEINS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; MCF-7 CELLS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS C-MYC; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84874785567     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.144     Document Type: Article

References (45)

1. Levens D. You don't muck with Myc. Genes Cancer 2010; 1: 547-554.
2. Gregory MA, Hann SR. c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells. Mol Cell Biol 2000; 20: 2423-2435.
3. Salghetti SE, Young Kim S, Tansey WP. Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. EMBO J 1999; 18: 717-726.
4. Herbst A, Salghetti SE, Kim SY, Tansey WP. Multiple cell-Type-specific elements regulate Myc protein stability. Oncogene 2004; 23: 3863-3871.
5. Clark HM, Yano T, Otsuki T, Jaffe ES, Shibata D, Raffeld M et al. Mutations in the coding region of c-MYC in AIDS-associated and other aggressive lymphomas. Cancer Res 1994; 54: 3383.
6. Shindo H, Tani E, Matsumuto T, Hashimoto T, Furuyama J. Stabilization of c-myc protein in human glioma cells. Acta Neuropathol 1993; 86: 345-352.
7. Kim SY, Herbst A, Tworkowski KA, Salghetti SE, Tansey WP. Skp2 regulates Myc protein stability and activity. Mol Cell 2003; 11: 1177-1188.
8. von der Lehr N, Johansson S, Wu S, Bahram F, Castell A, Cetinkaya C et al. The F-Box protein Skp2 participates in c-Myc Proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. Mol Cell 2003; 11: 1189-1200.
9. Welcker M, Orian A, Jin J, Grim JE, Harper JW, Eisenman RN et al. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation- dependent c-Myc protein degradation. Proc Natl Acad Sci USA 2004; 101: 9085-9090.
10. Yada M, Hatakeyama S, Kamura T, Nishiyama M, Tsunematsu R, Imaki H et al. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J 2004; 23: 2116-2125.
11. Adhikary S, Marinoni F, Hock A, Hulleman E, Popov N, Beier R et al. The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation. Cell 2005; 123: 409-421.
12. Popov N, Schu? lein C, Jaenicke LA, Eilers M. Ubiquitylation of the amino terminus of Myc by SCFb-TrCP antagonizes SCFFbw7-mediated turnover. Nat Cell Biol 2010; 12: 973-981.
13. Choi SH, Wright JB, Gerber SA, Cole MD. Myc protein is stabilized by suppression of a novel E3 ligase complex in cancer cells. Genes Dev 2010; 24: 1236-1241.
14. Henriksson M, Classon M, Axelson H, Klein G, Thyberg J. Nuclear colocalization of c-myc protein and hsp70 in cells transfected with human wild-Type and mutant c-myc genes. Exp Cell Res 1992; 203: 383-394.
15. Carystinos GD, Kandouz M, Alaoui-Jamali MA, Batist G. Unexpected induction of the human connexin 43 promoter by the ras signaling pathway is mediated by a novel putative promoter sequence. Mol Pharmacol 2003; 63: 821-831.
16. Ballinger CA, Connell P, Wu Y, Hu Z, Thompson LJ, Yin LY et al. Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions. Mol Cell Biol 1999; 19: 4535-4545.
17. Meacham GC, Patterson C, Zhang W, Younger JM, Cyr DM. The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation. Nat Cell Biol 2001; 3: 100-105.
18. Ding X, Goldberg MS. Regulation of LRRK2 stability by the E3 ubiquitin ligase CHIP. PLoS ONE 2009; 4: e5949.
19. Ko HS, Bailey R, Smith WW, Liu Z, Shin JH, Lee YI et al. CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation, and toxicity. Proc Natl Acad Sci USA 2009; 106: 2897-2902.
20. Li X, Huang M, Zheng H, Wang Y, Ren F, Shang Y et al. CHIP promotes Runx2 degradation and negatively regulates osteoblast differentiation. J Cell Biol 2008; 181: 959-972.
21. McLean PJ, Klucken J, Shin Y, Hyman BT. Geldanamycin induces Hsp70 and prevents [alpha]-synuclein aggregation and toxicity in vitro. Biochem Biophys Res Commun 2004; 321: 665-669.
22. Sittler A, Lurz R, Lueder G, Priller J, Lehrach H, Hayer-Hartl MK et al. Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington's disease. Hum Mol Genet 2001; 10: 1307-1315.
23. Pulverer BJ, Fisher C, Vousden K, Littlewood T, Evan G, Woodgett JR et al. Sitespecific modulation of c-Myc cotransformation by residues phosphorylated in vivo. Oncogene 1994; 9: 59-70.
24. Bhatia K, Huppi K, Spangler G, Siwarski D, Iyer R, Magrath I et al. Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas. Nat Genet 1993; 5: 56-61.
25. Patel JH, Loboda AP, Showe MK, Showe LC, McMahon SB. Analysis of genomic targets reveals complex functions of MYC. Nat Rev Cancer 2004; 4: 562-568.
26. The Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008; 455: 1061-1068.
27. Lissanu Deribe Y, Wild P, Chandrashaker A, Curak J, Schmidt MH, Kalaidzidis Y et al. Regulation of epidermal growth factor receptor trafficking by lysine deacetylase HDAC6. Sci Signal 2009; 2: ra84.
28. Xu W, Marcu M, Yuan X, Mimnaugh E, Patterson C, Neckers L et al. Chaperonedependent E3 ubiquitin ligase CHIP mediates a degradative pathway for c-ErbB2/ Neu. Proc Natl Acad Sci USA 2002; 99: 12847-12852.
29. Li F, Xie P, Fan Y, Zhang H, Zheng L, Gu D et al. C terminus of Hsc70-interacting protein promotes smooth muscle cell proliferation and survival through ubiquitin- mediated degradation of FoxO1. J Biol Chem 2009; 284: 20090-20098.
30. Dickey CA, Koren J, Zhang YJ, Xu YF, Jinwal UK, Birnbaum MJ et al. Akt and CHIP coregulate tau degradation through coordinated interactions. Proc Natl Acad Sci USA 2008; 105: 3622-3627.
31. Grobben B, De Deyn PP, Slegers H. Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion. Cell Tissue Res 2002; 310: 257-270.
32. Whittle IR, Macarthur DC, Malcolm GP, Li M, Washington K, Ironside JW et al. Can experimental models of rodent implantation glioma be improved? A study of pure and mixed glioma cell line tumours. J Neurooncol 1998; 36: 231-242.
33. Nagano N, Sasaki H, Aoyagi M, Hirakawa K. Invasion of experimental rat brain tumor: early morphological changes following microinjection of C6 glioma cells. Acta Neuropathol 1993; 86: 117-125.
34. Nie L, Wu H, Sun X-H. Ubiquitination and degradation of Tal1/SCL are induced by notch signaling and depend on Skp2 and CHIP. J Biol Chem 2008; 283: 684-692.
35. Imai Y, Soda M, Hatakeyama S, Akagi T, Hashikawa T, Nakayama KI et al. CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity. Mol Cell 2002; 10: 55-67.
36. Xia T, Dimitropoulou C, Zeng J, Antonova GN, Snead C, Venema RC et al. Chaperone- dependent E3 ligase CHIP ubiquitinates and mediates proteasomal degradation of soluble guanylyl cyclase. Am J Physiol Heart Circ Physiol 2007; 293: H3080-H3087.
37. Belova L, Sharma S, Brickley DR, Nicolarsen JR, Patterson C, Conzen SD et al. Ubiquitin-proteasome degradation of serum-and glucocorticoid-regulated kinase-1 (SGK-1) is mediated by the chaperone-dependent E3 ligase CHIP. Biochem J 2006; 400: 235.
38. Kundrat L, Regan L. Balance between folding and degradation for Hsp90- dependent client proteins: a key role for CHIP. Biochemistry 2010; 49: 7428-7438.
39. Kajiro M, Hirota R, Nakajima Y, Kawanowa K, So-ma K, Ito I et al. The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways. Nat Cell Biol 2009; 11: 312-319.
40. Ghosh MK, Sharma P, Harbor PC, Rahaman SO, Haque SJ. PI3K-AKT pathway negatively controls EGFR-dependent DNA-binding activity of Stat3 in glioblastoma multiforme cells. Oncogene 2005; 24: 7290-7300.
41. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex. Science 2005; 307: 1098-1101.
42. Ghosh MK, Harter ML. A viral mechanism for remodeling chromatin structure in G0 cells. Mol Cell 2003; 12: 255-260.
43. Sha J, Ghosh MK, Zhang K, Harter ML. E1A interacts with two opposing transcriptional pathways to induce quiescent cells into S phase. J Virol 2010; 84: 4050-4059.
44. Hatakeyama S, Yada M, Matsumoto M, Ishida N, Nakayama K-I. U. Box proteins as a new family of ubiquitin-protein ligases. J Biol Chem 2001; 276: 33111-33120.
45. Dai Q, Zhang C, Wu Y, McDonough H, Whaley RA, Godfrey V et al. CHIP activates HSF1 and confers protection against apoptosis and cellular stress. EMBO J 2003; 22: 5446-5458.